This proposal is submitted for the purpose of continuing the functional and structural analyses of components of the human renal/urinary kinin-forming system, clarifying their relationships to similar enzymes from other human tissues and cells and examining their possible roles in renal function or pathophysiology. Kinetic and structural characterization of the interaction of urinary, pancreatic and salivary kallikreins with fully functionally active, intact high and low molecular weight kininogens; purification and characterization of latent (trypsin-activatable) kallikrein from human urine; and immunochemical localization of kallikreins in human tissue will all be continued in studies that have developed from the findings of the previous project period. The purification of latent urinary kallikrein and elucidation of its relationships to the active urinary enzyme will permit the purification, characterization, and immunohistochemical localization of a latent kallikrein activator, as well as the development and application of a radioimmunoassay to determine the role of the activator in renal function. The purification and analytical procedures developed for latent kallikrein will be applied to the purification and comparative structural and functional analysis of human renal prokallikrein. The elicitation and characterization of specific anti-kallikrein antibodies and the use of one of them to develop a kallikrein radioimmunoassay lay the groundwork for the preparation and analysis of anti-urinary kallikrein monoclonal antibodies to be used for further structural analyses of human tissue kallikreins and their related latent or precursor forms; in continued immunohistochemical localization studies; and in the development of immunoaffinity purification techniques. These monoclonal anti-kallikreins together with polyclonal antibodies specific for renal kallikrein activator(s) or kininases will be used in the development of specific radioimmunoassays to further examine the role of these components of the renal kinin-forming system in regulating salt and water clearance in normal individuals and in patients with altered renal function.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL035949-04
Application #
3350412
Study Section
Cardiovascular and Pulmonary Research B Study Section (CVB)
Project Start
1985-07-01
Project End
1990-06-30
Budget Start
1988-07-01
Budget End
1990-06-30
Support Year
4
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Weinblatt, M; Helfgott, S; Coblyn, J et al. (1991) The effects of cyclosporin A on eicosanoid excretion in patients with rheumatoid arthritis. Arthritis Rheum 34:481-5
Anbar, R D; Lapey, A; Khaw, K T et al. (1990) Does lithium carbonate affect the ion transport abnormality in cystic fibrosis? Pediatr Pulmonol 8:82-8
Spragg, J; Vavrek, R J; Stewart, J M (1989) Inhibition of human and rat tissue kallikreins by peptide analog antagonists of bradykinin. Adv Exp Med Biol 247B:277-81
Spragg, J; Tilney, N L; Weinblatt, M E (1989) Human renal kallikrein-kinin system after engraftment and/or immunosuppression. Prog Clin Biol Res 297:325-38
Okunishi, H; Spragg, J; Burton, J et al. (1989) In vivo inhibition of tissue kallikreins by kininogen sequence analogue peptides. Adv Exp Med Biol 247B:23-8
Spragg, J; Weinblatt, M E; Coblyn, J et al. (1988) Effect of cyclosporine on urinary kallikrein excretion in patients with rheumatoid arthritis. J Lab Clin Med 112:324-32
Spragg, J; Vavrek, R J; Stewart, J M (1988) The inhibition of glandular kallikrein by peptide analog antagonists of bradykinin. Peptides 9:203-6
Weinblatt, M E; Coblyn, J S; Fraser, P A et al. (1987) Cyclosporin A treatment of refractory rheumatoid arthritis. Arthritis Rheum 30:11-7